trending Market Intelligence /marketintelligence/en/news-insights/trending/weffly7mj548kgh3mwhuiq2 content esgSubNav
In This List

Altimmune CFO resigns; interim replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Altimmune CFO resigns; interim replacement named

Altimmune Inc. said Elizabeth Czerepak resigned as the company's CFO and executive vice president of corporate development.

Czerepak, who also performed the functions of the company's principal accounting officer, left to pursue other opportunities.

The Gaithersburg, Md.-based biotechnology company named Will Brown as acting CFO and principal accounting officer until a replacement is found.

Brown has been engaged by Altimmune as an independent consultant since February.